KLF3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.859000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.539600E-01
Normal-vs-Stage2
2.108400E-01
Normal-vs-Stage3
6.318800E-01
Normal-vs-Stage4
9.940200E-02
Stage1-vs-Stage2
4.523800E-01
Stage1-vs-Stage3
9.767800E-01
Stage1-vs-Stage4
1.298360E-01
Stage2-vs-Stage3
5.092200E-01
Stage2-vs-Stage4
4.478100E-02
Stage3-vs-Stage4
2.038600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.042200E-01
Normal-vs-AfricanAmerican
2.722200E-01
Normal-vs-Asian
3.876400E-01
Caucasian-vs-AfricanAmerican
6.434800E-01
Caucasian-vs-Asian
8.900800E-01
AfricanAmerican-vs-Asian
6.635400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.595000E-01
Normal-vs-Female
3.395400E-01
Male-vs-Female
3.245000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.778800E-01
Normal-vs-Age(41-60Yrs)
1.668820E-01
Normal-vs-Age(61-80Yrs)
3.640800E-01
Normal-vs-Age(81-100Yrs)
3.103000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.638160E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.531200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.295600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.011760E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.210200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.400600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.720600E-01
Normal-vs-Daily Drinker
4.053800E-01
Normal-vs-Weekly Drinker
5.666800E-01
Normal-vs-Occasional Drinker
2.133800E-01
Normal-vs-Social Drinker
1.271000E-01
Non Drinker-vs-Daily Drinker
6.935400E-01
Non Drinker-vs-Weekly Drinker
7.765800E-01
Non Drinker-vs-Occasional Drinker
3.143800E-01
Non Drinker-vs-Social Drinker
7.804600E-01
Daily Drinker-vs-Weekly Drinker
6.069000E-01
Daily Drinker-vs-Occasional Drinker
6.307200E-01
Daily Drinker-vs-Social Drinker
5.393000E-01
Weekly Drinker-vs-Occasional Drinker
3.226200E-01
Weekly Drinker-vs-Social Drinker
9.156600E-01
Occasional Drinker-vs-Social Drinker
2.018800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.590200E-01
Normal-vs-Grade 2
3.765600E-02
Normal-vs-Grade 3
3.157700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.339000E-03
Grade 1-vs-Grade 3
4.997100E-03
Grade 1-vs-Grade 4
2.590200E-01
Grade 2-vs-Grade 3
7.106400E-01
Grade 2-vs-Grade 4
3.765600E-02
Grade 3-vs-Grade 4
3.157700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.571600E-01
Normal-vs-NonDiabetic
3.128800E-01
Diabetic-vs-NonDiabetic
4.559000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.545980E-02
Normal-vs-NoPancreatitis
3.731800E-01
Pancreatitis-vs-NoPancreatitis
1.908630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.611000E-01
Normal-vs-N1
2.307800E-01
N0-vs-N1
1.954200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.209900E-02
Normal-vs-TP53-NonMutant
4.467200E-01
TP53-Mutant-vs-TP53-NonMutant
5.59209999999588E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
